Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Facilitating Alzheimer's disease drug development in the United States
- PMID: 19328440
- PMCID: PMC2750898
- DOI: 10.1016/j.jalz.2009.01.005
Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Facilitating Alzheimer's disease drug development in the United States
Comment on
-
A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.Alzheimers Dement. 2009 Mar;5(2):85-92. doi: 10.1016/j.jalz.2009.01.021. Alzheimers Dement. 2009. PMID: 19328434 Free PMC article.
Similar articles
-
Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Establishing a national biomarker database: utility and incentives.Alzheimers Dement. 2009 Mar;5(2):108-13. doi: 10.1016/j.jalz.2009.01.015. Alzheimers Dement. 2009. PMID: 19328437 No abstract available.
-
Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." A national registry to identify a cohort for Alzheimer's disease prevention studies.Alzheimers Dement. 2009 Mar;5(2):128-9. doi: 10.1016/j.jalz.2009.01.018. Alzheimers Dement. 2009. PMID: 19328441 Free PMC article. No abstract available.
-
A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.Alzheimers Dement. 2009 Mar;5(2):85-92. doi: 10.1016/j.jalz.2009.01.021. Alzheimers Dement. 2009. PMID: 19328434 Free PMC article.
-
Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." A proposal to increase participation in Alzheimer's disease clinical trials.Alzheimers Dement. 2009 Mar;5(2):140-2. doi: 10.1016/j.jalz.2009.01.004. Alzheimers Dement. 2009. PMID: 19328445 No abstract available.
-
Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Prevention trials in persons at risk for dominantly inherited Alzheimer's disease: opportunities and challenges.Alzheimers Dement. 2009 Mar;5(2):166-71. doi: 10.1016/j.jalz.2008.12.002. Alzheimers Dement. 2009. PMID: 19328453 Free PMC article. Review.
Cited by
-
Quantitative structural MRI for early detection of Alzheimer's disease.Expert Rev Neurother. 2010 Nov;10(11):1675-88. doi: 10.1586/ern.10.162. Expert Rev Neurother. 2010. PMID: 20977326 Free PMC article. Review.
-
Mild cognitive impairment: baseline and longitudinal structural MR imaging measures improve predictive prognosis.Radiology. 2011 Jun;259(3):834-43. doi: 10.1148/radiol.11101975. Epub 2011 Apr 6. Radiology. 2011. PMID: 21471273 Free PMC article.
-
Current treatment and recent clinical research in Alzheimer's disease.Mt Sinai J Med. 2010 Jan-Feb;77(1):3-16. doi: 10.1002/msj.20165. Mt Sinai J Med. 2010. PMID: 20101716 Free PMC article. Review.
References
-
- McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group. Neurology. 1984;34:939–944. - PubMed
-
- Reiman EM, Caselli RJ, Chen K, Alexander GE, Bandy D, Frost J. Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer’s disease. Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3334–3339. - PMC - PubMed
-
- Fagan AM, Roe CM, Xiong C, Mintun MA, Morris JC, Holtzman DM. Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults. Arch Neurol Mar. 2007;64(3):343–349. - PubMed
-
- Pike KE, Savage G, Villemagne VL, et al. Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer’s disease. Brain Nov. 2007;130(Pt 11):2837–2844. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical